CARDIOVASCULAR SAFETY OF BCR-ABL1 TYROSINE KINASE INHIBITORS: IMATINIB AND PONATINIB DECREASE PLASMA CHOLESTEROL AND ATHEROSCLEROSIS IN APOE3*LEIDEN.CETP MICE